2.92

2.67% -0.08

Dare Bioscience Inc (DARE)

Überblick Nachrichten Preisverlauf Financials Forum Prognose Aktiensplit

Schlusskurs vom Vortag:

$3.00

Offen:

$3.0046

24-Stunden-Volumen:

15,315

Relative Volume:

0.43

Marktkapitalisierung:

$25.41M

Einnahmen:

Nettoeinkommen (Verlust:

$-30.16M

KGV:

-8.5882

EPS:

-0.34

Netto-Cashflow:

$-39.49M

1W Leistung:

-3.63%

1M Leistung:

-7.89%

6M Leistung:

-11.78%

1J Leistung:

+534.37%

1-Tages-Spanne:

$2.92

$3.02

1-Wochen-Bereich:

$2.92

$3.0301

52-Wochen-Spanne:

$0.28

$4.60

Dare Bioscience Inc Stock (DARE) Company Profile

Firmenname

Dare Bioscience Inc

Sektor

Healthcare (1169)

Branche

Biotechnology (679)

Telefon

858-926-7655

Adresse

3655 NOBEL DRIVE, SAN DIEGO, CA

Mitarbeiter

Twitter

@DareBioscience

Nächster Verdiensttermin

2024-11-07

Neueste SEC-Einreichungen

DARE's Discussions on Twitter

Vergleichen Sie DARE mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
DARE Dare Bioscience Inc	2.92	25.41M	0	-30.16M	-39.49M	-0.34
VRTX Vertex Pharmaceuticals Inc	502.92	129.14B	11.02B	-535.60M	-978.00M	-2.20
REGN Regeneron Pharmaceuticals Inc	680.61	74.41B	14.20B	4.41B	3.54B	38.28
ARGX Argen X Se Adr	581.21	35.31B	2.19B	833.04M	-1.28B	12.71
ALNY Alnylam Pharmaceuticals Inc	241.75	31.30B	2.25B	-278.16M	-42.59M	-2.17
ONC Beigene Ltd Adr	254.57	27.35B	3.32B	-860.46M	-1.04B	-8.32

Dare Bioscience Inc Aktie (DARE) Neueste Nachrichten

Feb 20, 2025

Dare Bioscience, Inc. to Host Earnings Call - ACCESS Newswire

Feb 20, 2025

Daré Bioscience and Theramex Announce Co-Development and - GlobeNewswire

Feb 20, 2025

Dare Bioscience and Theramex Announce Co-Development and Licensing Agreement for A Potential Biodegradable Long-Acting Contraceptive Implant - Marketscreener.com

Feb 20, 2025

Daré, Theramex partner on biodegradable contraceptive implant - Investing.com

Feb 20, 2025

Daré, Theramex partner on biodegradable contraceptive implant By Investing.com - Investing.com South Africa

Feb 20, 2025

Revolutionary Contraceptive Tech: This New Implant Actually Dissolves After Use - StockTitan

Feb 20, 2025

Feb 14, 2025

Dare Bioscience risks Nasdaq delisting over market value - MSN

Feb 14, 2025

Feb 12, 2025

Dare Bioscience (NASDAQ: DARE) Files 8-K with SEC Regarding Corporate Presentation - Defense World

Feb 12, 2025

Feb 10, 2025

Daré Bioscience to Present at BIO CEO Conference - TipRanks

Feb 10, 2025

Feb 07, 2025

Dare Bioscience secures additional NIAID funding for HPV treatment - MSN

Feb 07, 2025

Dare Bioscience secures additional NIAID funding for HPV treatment By Investing.com - Investing.com Nigeria

Feb 07, 2025

Feb 06, 2025

Daré Bioscience Announces Funding Award Notice from the - GlobeNewswire

Feb 06, 2025

Daré Bioscience Announces Funding Award Notice from the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to Support DARE-HPV Development - The Manila Times

Feb 06, 2025

Revolutionary HPV Treatment Gets $12M Funding Boost: A New Hope for Cervical Health - StockTitan

Feb 06, 2025

Jan 28, 2025

Daré Bioscience (NASDAQ:DARE) Shares Cross Below 200-Day Moving Average – Time to Sell? - Defense World

Jan 28, 2025

Jan 20, 2025

Daré Bioscience (NASDAQ:DARE) Prepares to Share Corporate Presentation on January 13, 2025 - Defense World

Jan 20, 2025

Jan 14, 2025

Geode Capital Management LLC Decreases Stock Holdings in Daré Bioscience, Inc. (NASDAQ:DARE) - Defense World

Jan 14, 2025

Daré Bioscience (NASDAQ:DARE) Share Price Crosses Above Fifty Day Moving Average – Time to Sell? - Defense World

Jan 14, 2025

Jan 13, 2025

Daré Bioscience Announces New Corporate Presentation - TipRanks

Jan 13, 2025

Jan 09, 2025

Daré Bioscience to Participate in the Women's Health Series at the 43rd Annual J.P. Morgan Healthcare Conference - The Manila Times

Jan 09, 2025

Daré Bioscience to Participate in the Women’s Health Series at the 43rd Annual J.P. Morgan Healthcare Conference - GlobeNewswire

Jan 09, 2025

Daré Bioscience CEO to Spotlight Women's Health Innovation at J.P. Morgan Healthcare Conference - StockTitan

Jan 09, 2025

Jan 05, 2025

State Street Corp Lowers Stake in Daré Bioscience, Inc. (NASDAQ:DARE) - Defense World

Jan 05, 2025

Jan 02, 2025

Daré Bioscience, Inc. and ARPA-H Ring the Nasdaq Stock Market Closing Bell - Nasdaq

Jan 02, 2025

Daré Bioscience, Inc. and ARPA-H Ring the Closing Bell - Nasdaq

Jan 02, 2025

Daré Bioscience (NASDAQ:DARE) Shares Pass Below 200-Day Moving Average – Time to Sell? - Defense World

Jan 02, 2025

Dec 25, 2024

Daré Bioscience (NASDAQ:DARE) Share Price Passes Below Two Hundred Day Moving Average – Here’s What Happened - Defense World

Dec 25, 2024

Dec 19, 2024

DARE Stock Touches 52-Week Low at $3.04 Amid Market Challenges - Investing.com

Dec 19, 2024

Dec 18, 2024

Daré Bioscience Announces Phase 3 Plans for Sildenafil Cream Development to Address Female Sexual Arousal Disorder - Defense World

Dec 18, 2024

Dec 16, 2024

Daré Bioscience to initiate phase 3 study of FSAD treatment - Investing.com

Dec 16, 2024

Daré Bioscience Announces Phase 3 Plans for Sildenafil Cream, 3.6%, in the Treatment of Female Sexual Arousal Disorder (FSAD) - The Manila Times

Dec 16, 2024

Daré Bioscience Announces Phase 3 Plans for Sildenafil - GlobeNewswire

Dec 16, 2024

Daré Bioscience Advances First-Ever FSAD Treatment: Phase 3 Trial Set for Breakthrough Female Sexual Health Drug - StockTitan

Dec 16, 2024

Dec 10, 2024

Daré Bioscience Announces Publication in Sexual Medicine of - GlobeNewswire

Dec 10, 2024

Daré Bioscience's Sildenafil Cream Shows Promising Clinical Data for Female Sexual Health Treatment - StockTitan

Dec 10, 2024

Dec 05, 2024

Daré Bioscience receives $2.5 million for contraceptive tech By Investing.com - Investing.com Canada

Dec 05, 2024

Dec 04, 2024

Daré Bioscience receives $2.5 million for contraceptive tech - Investing.com India

Dec 04, 2024

DAREDare Bioscience, Inc. Latest Stock News & Market Updates - StockTitan

Dec 04, 2024

Daré Bioscience Announces $2.5 Million Grant Funding - GlobeNewswire

Dec 04, 2024

Daré Bioscience Announces $2.5 Million Grant Funding Installment to Support Further Development of Novel Contraceptive Technology DARE-LARC1 - The Manila Times

Dec 04, 2024

Daré Bioscience Advances Revolutionary Wireless Contraceptive Tech With $2.5M Grant Milestone - StockTitan

Dec 04, 2024

Nov 27, 2024

Dare Bioscience Q3 2024 Earnings Preview - MSN

Nov 27, 2024

Nov 26, 2024

Analyzing Vistagen Therapeutics (NASDAQ:VTGN) and Daré Bioscience (NASDAQ:DARE) - Defense World

Nov 26, 2024

Nov 23, 2024

Daré Bioscience, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 23, 2024

Nov 20, 2024